{"nctId":"NCT00255125","briefTitle":"Role of Soy Supplementation in Prostate Cancer Development","startDateStruct":{"date":"2005-09"},"conditions":["Prostate Neoplasm"],"count":86,"armGroups":[{"label":"Arm Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]},{"label":"Arm Soy Supplement","type":"EXPERIMENTAL","interventionNames":["Drug: Soy Supplement"]}],"interventions":[{"name":"Soy Supplement","otherNames":["Fla-vien"]},{"name":"Placebo","otherNames":["No other name"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Histologically proven prostate cancer.\n* Surgical candidate for prostatectomy.\n* During study period, must agree not to take new supplements.\n* No concurrent chemotherapy, radiation or hormonal therapy.\n* No history of prior allergy to soy based products.\n* Must not have been taking soy supplements or soy isoflavones within 90 days prior to study enrollment.\n* Must be able to safely be on study supplements for period of at least two weeks prior to scheduled prostatectomy.\n* Must give written and informed consent in accordance with institutional and federal guidelines.\n\nExclusion Criteria:\n\nDuring study period, must agree not to take new supplements.\n\n* No concurrent chemotherapy, radiation or hormonal therapy.\n* No history of prior allergy to soy based products.\n* Must not have been taking soy supplements or soy isoflavones within 90 days prior to study enrollment.\n* Must be able to safely be on study supplements for period of at least two weeks prior to scheduled","healthyVolunteers":false,"sex":"MALE","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Effect of Soy Isoflavones on Serum Testosterone Levels.","description":"Total testosterone (ng/ml) serum levels were measured at the time of enrollment(baseline), after two weeks on soy supplement(time point 1), and just prior to prostatectomy (time point 2). All patients must have completed at least two week of soy supplement or placebo and time point 3 varied depending on date of planned prostatectomy. Results were analyzed and are reported at the two week time period, comparing between patients receiving soy supplement or placebo.","paramType":"MEAN","dispersionType":"80% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"376","spread":null},{"groupId":"OG001","value":"405","spread":null}]}]}]},{"type":"SECONDARY","title":"Effect of Soy Isoflavones on Estrogen Receptor Status","description":"Samples of the prostate cancer tissue (paraffin embedded) were sectioned and placed on a glass slide. Using immunohistochemistry and an estrogen receptor antibody, sections were stained and assess to determine the extent of estrogen receptor expression. Patients in the soy supplement arm's samples results were compared to placebo arm results.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"130","spread":"58"},{"groupId":"OG001","value":"131","spread":"56"}]}]}]},{"type":"SECONDARY","title":"Molecular Effects of Soy Supplementation Compared to Placebo.","description":"Using a tissue microarray targeting the cell cycle, selected fresh prostate cancer samples were evaluated in patients in the soy supplement arm compared to the placebo arm.","paramType":null,"dispersionType":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2,"n":42},"commonTop":["GI symptoms"]}}}